/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
Key Takeaways The FTC is intensifying scrutiny of practices that delay generic and biosimilar entry.Strategies that extend exclusivity...
A Fresh Take
Insights on US legal developments
After nearly three years of controversy, the long-awaited U.S. implementation of Basel III endgame is getting a do-over. On March 19,...
On March 19, 2026, the U.S. Court of Appeals for the Fifth Circuit denied the Federal Trade Commission’s (FTC) emergency motion for a...
Subscription services are a core marketing tool in today’s economy. But the Federal Trade Commission (FTC) is increasingly concerned that...
As expected, the FTC has released the text of its Advance Notice of Proposed Rulemaking (ANPRM) regarding fees in the rental housing...
On March 9, 2026, the Foreign Corrupt Practices Act Reinforcement Act was introduced by a coalition of 14 Senate Democrats, spearheaded...
As covered in our previous post, on February 20, 2026, the US Supreme Court ruled that the International Emergency Economic Powers Act...
We know you missed us, so we are back to examine some more pitfalls that may be unidentified or ignored until they are those monsters...
On January 30, 2026, the Federal Trade Commission (FTC) announced that it has issued two Advance Notices of Proposed Rulemaking (ANPRMs):...
On March 6, 2026, President Trump signed an Executive Order (“EO”) titled "Combating Cybercrime, Fraud, and Predatory Schemes Against...
On March 10, 2026, the US Department of Justice (DOJ) released what it described as its first-ever Department-wide corporate enforcement...
The increased prevalence of royalty-related disputes under license and collaboration agreements in the life sciences industry reflects...